KRYSTAL JOHNSON: Open Payments
NPI 1609597103 · BARBERTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 21 payments from 10 companies in 2025. Trend: 2023 $224 · 2024 $334 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: MOUNJARO, TRELEGY ELLIPTA, QULIPTA, Auvelity, UBRELVY, FARXIGA, XIFAXAN, ELIQUIS.
Industry payments across OH — which companies pay providers there.
